Background: Preterm birth has been linked to increased risk of autism spectrum disorders (ASD), but how this risk changes with gestational age at birth has not been well characterised, especially with regard to co-occurring intellectual disability (ID). Methods: Register-based cohort study of singleton births in 1984-2007 in Stockholm County, Sweden (N total: 480 728; n ASD: 10 025). We assessed overall and sex-specific, gestational week-specific prevalence estimates and risk ratios of ASD with and without ID. Results: Preterm and postterm births were associated with elevated risk of ASD, and the relationship between gestational age at birth and ASD with and without ID differed in males and females. Risk of ASD without ID was higher in preterm births among both sexes and decreased continuously with increasing length of gestation. Risk of ASD with ID was higher in both preterm and postterm births among both sexes, with postterm birth in females being more highly associated with ASD with ID than that in males. Conclusions: The relationship between gestational age at birth and ASD differs by the presence/absence of cooccurring ID and fetal sex. Both preterm and postterm birth are associated with increased risk of ASD. Risk of ASD is not constant within conventionally defined gestational age at birth periods. Further research on mechanism underlying these associations is needed.
with ASD had co-occurring ID. 7 The presence/ absence of ID is considered to be the most critical factor affecting outcomes in this population. 8 Gestational age at birth measures the duration of pregnancy and also is an established indicator of fetal growth maturity at birth. Preterm (gestational age at birth <37 weeks) and postterm (gestational age at birth ≥42 weeks) births account for about 10% and 7% of all births worldwide, respectively. 9, 10 Although the causes of preterm and postterm births have not been fully identified, genetics, maternal reproductive history, maternal health before and during pregnancy, as well as child characteristics including fetal sex have been reported to influence pregnancy duration. [9] [10] [11] [12] Both preterm and postterm births have been linked to elevated risk of ASD. For example, one Danish population-based study of over 1.7 million births reported that compared to individuals born at 40 weeks, the risk of ASD among those born at 24-27 weeks and 42-43 weeks were 3-14.7 and 1.0-1.2 times higher, respectively. 13 A recent meta-analysis identified 14
original research articles investigating the association between postterm birth and risk of ASD. 14 Of these, seven reported null findings, six reported a positive association, and one reported a negative association.
The pooled estimate suggested a slight increase in relative risk (RR) of ASD associated with postterm birth, although the 95% confidence interval (CI) was wide (RR 1.14, 95% CI 0.58, 2.24). Furthermore, phenotypic differences by sex have been noted in ASD, 15 and pregnancies with boys tend to be shorter. 11 However, prior investigations have not examined how associations may differ by sex for ASD with and without cooccurring ID in a large sample. [16] [17] [18] Although the relationship between preterm birth and risk of ASD has been suggested with categorical parametrisations of gestational age, 14 less is known about how risk of ASD changes across the full range of gestational age, especially among postterm births. In this study, we investigated the association between gestational age at birth and ASD with and without ID, and estimated overall and sex-specific prevalence at each week of gestational age at birth for deliveries at 27-43 weeks, using data from a large Swedish population-based record-linkage study. We hypothesised that the relationship between gestational age at birth and ASD without ID would be different from that between gestational age at birth and ASD with ID, and these relationships might be different in males and females. We examined singleton livebirths with complete data on ASD, ID, gestational age at birth, and sex (N total = 480 728, N ASD = 10 025). Data on all other variables except maternal smoking were complete. Maternal smoking data were available for 90% of individuals. Figure 1 shows the derivation of the study sample. Because perinatal risk profiles including mortality, gestational age at birth, and birthweight are very different between singleton and multiple births, 1 we excluded multiple births from the study. In addition, we excluded 137 individuals with improbable birthweights using methods we have applied in a previous study. 20 
Methods

Study population
Variables
Gestational age, gestational diabetes, hypertension, parity, birthweight, and maternal smoking were obtained from the MBR. The MBR uses information from several variables to hierarchically determine gestational age -first from ultrasound-based estimate, then from date of last menstrual period, paediatric record, and birthweight. About 90% of gestational age at birth data on births during the study period were based on ultrasound results, followed by about 8% that were based on date of last menstrual period. 21 Gestational age in weeks rounded to the nearest tenth was used in the analysis. Gestational diabetes (ICD-10 O24.4 and ICD-9 648W) and hypertension (ICD-10 I10-I13 and O10-O11, ICD-9 401-404, 642A-642C, ICD-8 400, 401, 402, 403, and 404) were identified using ICD codes. 19 Parity was categorised as 1, 2, and ≥3 in the analysis. Birthweight-for-gestational age z-scores were calculated from birthweight and gestational age at birth data using separate national references for boys and girls. 3 Paternal and maternal ages at delivery were calculated based on each parent's date of birth. Parental history of neurologic and psychiatric disorders data was extracted from regional and national registers as previously described and coded as one binary variable (yes/no history) for each parent. 22 Disposable family income data were obtained from the Integrated Database for Labour Market Research, were adjusted for family size and inflation, and accounted for all sources of income. This variable was categorised into quintiles based on national data. 22 Maternal country of birth data was obtained from the Total Population Register and was categorised as mother 'born in Sweden', 'in another European country', or 'outside Europe'. Maternal self-reported smoking during pregnancy was obtained from the MBR and was categorised as 'yes', 'no', or 'unknown'.
Statistical analysis
We used cubic splines in generalised additive models (GAM) to model the association of gestational age at birth with the risk of ASD, 23 adjusting for potential confounders identified a priori from the literature. 6, 14, 24 Covariates included in the GAM were as follows: sex-adjusted birthweight-for-gestational age z-scores, offspring sex, birth year, paternal and maternal ages and their interaction, 22 maternal smoking, paternal and maternal neuropsychiatric histories, parity, gestational diabetes, hypertension, family income quintiles, and maternal country of origin. We included a random intercept for sibship in the model to account for clustering of unmeasured familial components in ASD, 25 preterm 12 and postterm 26 birth, and conducted a sensitivity analysis only on nonsiblings (i.e. one child from each family was chosen at random to be included in this analysis), using the same variables and model specifications as those used in the analysis of the total sample. Sex-specific associations were assessed using the likelihood ratio test comparing nested models with and without an interaction term between sex and gestational age. In sex-stratified analyses, we used the same model specification to estimate the association of gestational age at birth and risk of ASD with and without co-occurring ID separately in males and females. From expected probabilities of ASD based on the multivariable GAM model, we calculated gestational age at birth-specific prevalence proportions associated with each week. 
Results
Sample characteristics
The study sample included 480 728 individuals. A total of 10 025 (2.1%) persons were diagnosed with ASD; of these, 2368 (23.6%) and 7657 (76.4%) were diagnosed with and without co-occurring ID, respectively.
There were some differences in sample characteristics by case status (Table 1) . For example, individuals with ASD were more likely to be male, first-born, from families with lower income, and born preterm or postterm. Individuals with ASD were also more likely to have mothers with gestational diabetes and hypertension, and parents with a history of neuropsychiatric disorders. The prevalence proportions of preterm and postterm birth were higher among individuals with ASD, especially those with co-occurring ID, than among those without ASD. The pattern of case distribution by gestational age at birth differed by sex (Table S1 ), although caution is warranted due to smaller strata sizes. Fewer females than males were affected by ASD with and without ID. Preterm and postterm births were more prevalent in both sexes among persons with ASD with and without ID.
Gestational age at birth and risk of ASD with and without ID As shown in Table 2 , the estimated prevalence of ASD decreased monotonically in births between 27 and 40 weeks, and then increased monotonically in births between 41 and 43 weeks. In Table S2 , we present results from sensitivity analysis on non-siblings. Prevalence estimates were slightly attenuated after accounting for unmeasured familial factors, but the trend of elevated risk in preterm and postterm births persisted. Estimated ASD prevalence was substantially higher for very preterm and postterm births compared to infants born at 40 weeks. For example, in Table 2 , among individuals born at 27 and 43 weeks, the expected prevalence of ASD was 52.4 (95% CI 42.3, 64.6) and 23.1 (95% CI 21.3, 25.0) per 1000, respectively; among those born at 40 weeks, the prevalence was estimated to be 19.8 (95% CI 19.3, 20.3) per 1000. Also, the risk of co-occurring ID among cases increased with decreasing length of gestation. Among births at 27 weeks, of the expected 52.4 (95% CI 42.3, 64.6) per 1000 affected individuals, about 41% of the cases were also expected to be affected by ID; in births at 40 weeks, the expected prevalence of cooccurring ID among cases was about 23%. A visualisation of these estimates is provided in Figure S1 .
Gestational age at birth and risk of ASD with/ without ID in girls and boys
Results from the sex-stratified analysis are presented in Table 3 . The relationship between gestational age at birth and ASD without ID did not differ by sex (likelihood ratio test P-value = 1), but the association between gestational age at birth and ASD with ID was different between males and females (likelihood ratio test P-value = 0.02). Expected prevalence of ASD without ID decreased continuously as gestational age at birth increased in both sexes. Risk of ASD with ID increased among postterm births in both males and females, with the strength of association in females being stronger. The expected prevalence of ASD with ID was 6.7 (95% CI 6.3, 7.1) and 8.0 (95% CI 6.7, 9.5) per 1000 among males born at 40 and 43 weeks, respectively; in other words, the risk of ASD with ID among males born at 43 weeks was about 1.2 times as high as the risk of ASD with ID among boys born at 40 weeks. This risk ratio (RR) among females born in these two gestational age at birth weeks was 1.4. In Table S3 , we presented this RR and its associated 95% CI, as well as RR estimates for births in other weeks of gestation between the 27th and the 43rd weeks. Visualisations for these estimates are provided in Figure S2 .
Comment
Principal findings
In this large population-based study, we investigated the relationship between gestational age at birth and ASD with and without ID and estimated ASD prevalence for births in each week of gestational age at birth. We also investigated whether these relationships differed in males and females. In summary, preterm and postterm births were associated with elevated risk of ASD with and without ID, and the pattern of these associations differed by sex. Risk of ASD without ID was higher in preterm births in both sexes and decreased continuously with increasing length of gestation. Risk of ASD with ID was higher in both preterm and postterm births in both sexes, with postterm birth in females being more highly associated with ASD with ID than that in males.
Interpretation
Consistent with previous findings, 13, 16 we observed a positive association between preterm birth and higher risk of ASD. Atlad ottir reported an inverse association between gestational age at birth and ASD with a risk curve whose shape was very similar to the observations reported here; however, the investigators did not separately consider ASD with and without ID. 16 D'Onofrio investigated the association of gestational age at birth with ASD and other morbidities using data on over three million singleton births in Sweden between 1973 and 2008. 13 In analyses using categories of gestational age, the investigators reported that compared to the risk of ASD for individuals born at 37-42 weeks, the risk for those born at 23-27 weeks, 28-30 weeks, 31-32 weeks, and 33-36 weeks was 3.2, 2.4, 1.7, and 1.3 times higher, respectively, also consistent with our results. Potential mechanisms that could explain this association include maternal health factors such as maternal pre-pregnancy obesity or infection during pregnancy, 4, 6 but this remains speculative.
These findings support a positive association between postterm birth and higher risk of ASD. Gardener pooled results from 14 studies and reported an expected increase in the risk of ASD by 14% among postterm births.
14 In our study, individuals born in the 43rd week were 13% more likely to be affected by ASD in reference to those born in the 40th week. Although yet to be replicated, the increase in expected prevalence of ASD was driven mainly by that of ASD with ID in our sample. Potential mechanisms underlying this association may include a greater likelihood of birth complications resulting in brain injuries leading to increased risk of ASD and ID during postterm delivery. 11, 12 The strength of association between postterm birth and risk of ASD with ID was modest, and our continuous, flexible parameterisation of gestational age at birth offered advantages in detecting weaker associations. Prior studies using categorical gestational age at birth intervals might have had limited statistical power to estimate this association. [27] [28] [29] [30] [31] Alternatively, different Table 3 . Prevalence estimates and associated 95% confidence intervals by weeks of gestational age at birth for autism spectrum disorders (ASD) overall, and ASD with and without intellectual disability (ID) in males and females reproductive and obstetric practices, as well as variations in ascertainment of gestational age at birth, ASD, and ID across countries may also have influenced the observed relationships. [28] [29] [30] [31] [32] In the analysis, we did not observe sex differences in patterns of association between gestational age at birth and risk of ASD without ID. Expected prevalence of ASD regardless of ID status was consistently higher in males than that in females. We did, however, observe different patterns of association between gestational age at birth and ASD with ID in males vs. females. Females born postterm were at somewhat higher risk of ASD with ID than males born in the same week. It has been previously reported that ASD with ID might be genetically distinct from ASD with ID, 2 and that specific cognitive skills and other ASD phenotypes may vary by sex. 15 Our findings suggest that the aetiology of ASD with ID may be different in males and females. However, as ASD prevalence is known to exhibit strong male predominance, there were few females with ASD in our sample, so our estimates for females are imprecise and need to be interpreted with caution.
Strengths
The access to a large, population-based, high-quality, prospectively collected data on prenatal and parental health, family income, and other important measures is a main strength of this study. Multi-register data linkage of a large volume of prospectively collect data enabled accurate and comprehensive capture of data on gestational age at birth and other pre-and perinatal variables, diagnoses, and parents' health. Characteristics of our study sample (such as the male predominance in ASD prevalence, higher proportion of persons affected by ASD having parents with neuropsychiatric disorders, and mothers with gestational diabetes and hypertension) were in agreement with existing findings. 14,24,29 Also, we were able to analyse the non-linearity of the association between gestational age at birth and ASD using GAMs.
Limitations of the data
As with most observational epidemiologic data, some measurement or misclassification error is expected for gestational age at birth and other variables. However, nearly all gestational age at birth measures were based on ultrasound measures during the prenatal period, so the best estimates were used in the analysis and any measurement error is likely to be small and non-differential with respect to outcome. We restricted our sample to singletons, so it is important to note that our findings cannot necessarily be generalised to individuals from multiple births. Finally, we did not examine potential mediation by general perinatal and neonatal risk factors, such as mode of delivery and more detailed birth complications. Such perinatal factors may increase risk of ASD and therefore may be on the causal pathway between gestational age at birth and ASD. 14 
Conclusions
We observed that preterm and postterm births were associated with elevated risk of ASD regardless of presence or absence of co-occurring ID, and the relationship between gestational age at birth and ASD with and without ID differed in males and females. Risk of ASD without ID was higher in preterm births, but not postterm births in both sexes. Risk of ASD with ID was higher in both preterm and postterm births in both sexes, with postterm birth in females being more highly associated with ASD with ID than that in males. These findings should be replicated using comparable approaches in other large data sets.
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